Dr. Gary Marklin Recognized as a St. Louis Titan 100

Published February 15, 2022 in Press Release

We are excited to announce that Mid-America Transplant’s Chief Medical and Research Officer, Dr. Gary Marklin, has been named as a 2022 Titan 100. 

The Titan 100 program recognizes St. Louis’ Top 100 CEO’s & C-level executives. They are the area’s most accomplished business leaders, demonstrating exceptional leadership, vision, and passion.  

“The Titan 100 are shaping the future of St. Louis’ business community by building a distinguished reputation that is unrivaled and preeminent in their field. We proudly recognize the Titan 100 for their successes and contributions. We know that they will have a profound impact that makes an extraordinary difference for their customers and clients across the nation.” says Jaime Zawmon, President of Titan CEO.

Dr. Marklin has practiced pulmonary and critical medicine in St. Louis for over 30 years and was the medical director of the ICU, respiratory therapy department, pulmonary rehab, and PFT/ABG lab at St. Anthony's Medical Center (now Mercy Hospital South) for 10 years.  

After serving as Mid-America Transplant’s associate medical director for six years, Dr. Marklin became the full-time chief medical and research officer in 2014. In this role, Dr. Marklin leads research efforts to increase donation and transplantation outcomes.  He also provides training for Mid-America Transplant’s clinical staff to ensure the organization’s mission is supported by a highly skilled staff.  Dr. Marklin’s clinical leadership has contributed to Mid-America Transplant achieving record-breaking years for organ and tissue donation, giving more people in the region a second chance at life.

Dr. Marklin embodies Mid-America Transplant’s core values of excellence, stewardship, compassion, innovation, integrity and collaboration. He says, “It is our responsibility to be the best stewards of the generous gifts donors and their families provide, and that means holding ourselves to the highest standards of excellence so more people can benefit from a lifesaving transplant.”

The 2022 Titan 100 class will be recognized at an awards ceremony on April 28.